In previous studies, we identified several enriched and depleted KEGG signaling pathways in a model of secondary dasatinib resistance in a distinct subtype of BCP-ALL, i.e., pre-BCR+/E2A-PBX1+, using gene ontology (GO) analysis [12]. This evidence concerns the gene BCR and acute lymphoblastic leukemia.